Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | BIIB | ILMN | ||
| Company | Intra-Cellular Ther | Biogen Inc | Illumina Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 131.90 | 123.70 | 81.00 | ||
| High | 131.98 | 125.77 | 84.04 | ||
| Low | 131.63 | 122.46 | 80.31 | ||
| Last | 131.87 | 125.59 | 83.62 | ||
| Change | -0.05 | +1.89 | +2.72 | ||
| % Change | -0.04% | +1.53% | +3.36% | ||
| Volume | 16,062,900 | 1,803,900 | 2,341,700 | ||
| 20-Day Average Volume | 2,474,570 | 1,666,310 | 2,069,040 | ||
| Previous Close | 131.92 | 123.70 | 80.90 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 131.51 | 120.32 | 77.64 | ||
| 20-Day Raw Stochastic | 86.25% | 98.29% | 97.04% | ||
| 20-Day Relative Strength | 82.75% | 51.16% | 53.77% | ||
| Weighted Alpha | +83.21 | -45.31 | -33.32 | ||
| Today's Opinion | 100% Buy | 88% Sell | 56% Sell | ||
| Previous Opinion | 100% Buy | 88% Sell | 64% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 03/25/25 | +6.28% since 05/09/25 | +10.37% since 05/09/25 | ||
| Low | 131.63 on 04/01/25 | 119.18 on 05/15/25 | 77.50 on 05/14/25 | ||
| High | 131.98 on 04/01/25 | 125.77 on 05/16/25 | 84.04 on 05/16/25 | ||
| 1-Month | |||||
| %Chg | +2.86% since 02/28/25 | +8.93% since 04/16/25 | +13.72% since 04/16/25 | ||
| Low | 131.18 on 03/05/25 | 114.66 on 04/17/25 | 69.83 on 04/21/25 | ||
| High | 131.98 on 04/01/25 | 125.77 on 05/16/25 | 84.04 on 05/16/25 | ||
| 3-Month | |||||
| %Chg | +57.89% since 12/31/24 | -8.55% since 02/14/25 | -16.58% since 02/14/25 | ||
| Low | 80.82 on 01/07/25 | 110.04 on 04/09/25 | 68.70 on 04/09/25 | ||
| High | 131.98 on 04/01/25 | 157.09 on 03/10/25 | 105.67 on 02/20/25 | ||
| 6-Month | |||||
| %Chg | +81.51% since 10/01/24 | -21.50% since 11/15/24 | -38.08% since 11/15/24 | ||
| Low | 70.90 on 10/07/24 | 110.04 on 04/09/25 | 68.70 on 04/09/25 | ||
| High | 131.98 on 04/01/25 | 165.29 on 12/02/24 | 153.06 on 01/14/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,047,056 | 18,402,448 | 13,237,046 | ||
| Shares Outstanding, K | 106,522 | 146,528 | 158,300 | ||
| Annual Sales | 680,850,000 | 9,675,900,000 | 4,372,000,000 | ||
| Annual Net Income | -74,680,000 | 1,632,200,000 | -1,223,000,000 | ||
| Last Quarter Sales | 199,220,000 | 2,431,000,000 | 1,041,000,000 | ||
| Last Quarter Net Income | -16,890,000 | 240,500,000 | 131,000,000 | ||
| 60-Month Beta | 0.46 | 0.12 | 1.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 02/21/25 | 3.02 on 05/01/25 | 0.97 on 05/08/25 | ||
| Latest Earnings Date | 05/06/25 | 05/01/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 7.82 | 24.29 | ||